Patent · US Active

Therapeutic formulations and uses thereof

US12409140B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Bionomics Limited · AU

Inventors

Dharam Paul · Yarrawonga, AU
Julia Crossman · Adelaide, AU
Elizabeth Doolin · Parramatta, AU
Tom Reynolds · Bend, US
Xiangming Wu · Bend, US
Jeff Millan · Bend, US
Thomas Stumpfig · Bend, US
Kristie Downing · Bend, US

Key dates

Filing date	Feb 17, 2020
Grant date	Sep 9, 2025
Priority date	—
Expiry date	Nov 13, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2013
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture thereof, and therapeutic methods and uses in the treatment of diseases of the central nervous system thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.